Azithromycin to prevent airway infections in young children with lung damage
Treatments studied
Part of Bones, joints & muscles, Genetic & congenital, Heart & circulation, Lungs & breathing, Skin clinical trials.
This trial tests whether giving a low dose of azithromycin (an antibiotic) can prevent lung infections in young children with structural lung damage or congenital lung/airway malformations. The goal is to reduce infections and keep lungs healthier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have confirmed structural lung damage or a congenital lung/airway malformation (seen on CT or bronchoscopy).
- Your child must be followed at one of three specialized pediatric pulmonology centers in Denmark.
- Your child must be at risk for or already have had respiratory infections that required antibiotics.
- Your child must be between 0 and 72 months old (under 6 years) at the start of the study.
- Your child cannot have cystic fibrosis, primary ciliary dyskinesia, certain heart conditions, or an allergy to macrolide antibiotics.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a common antibiotic called azithromycin can help prevent flare-ups (sudden worsening) of bronchiectasis—a lung condition where airways become permanently enlarged and damaged. Patients will take azithromycin or a placebo for 12 months to see if it reduces how often they get sick.
This trial tests whether the antibiotic azithromycin can help children in the hospital who are having asthma-like breathing symptoms. If you qualify, your child may get azithromycin as part of the study and will be monitored closely for side effects and breathing improvement.
This trial tests whether adding the antibiotic azithromycin to standard asthma treatments helps children with severe asthma in the pediatric intensive care unit (PICU) recover faster. It is for children ages 3 to 17 who are already receiving strong asthma medicines and steroids.
This trial tests whether azithromycin (an antibiotic) can improve outcomes for babies and young children in the ICU who have RSV causing serious breathing problems. It mainly looks at children who start strong breathing support soon after RSV symptoms begin.
This study tests whether giving a common antibiotic, azithromycin, to newborns with low birth weight can help them grow and stay healthier. It aims to see if this medicine can reduce infections and improve vitality in babies.
This Phase 4 study tests whether a long course of azithromycin can reduce flare-ups in people with chronic obstructive pulmonary disease (COPD) who have had recent exacerbations. It also looks at mucus properties and how flare-ups happen.
Hear when a new Tracheomalacia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.